Single stage bilateral total hip arthroplasty – 10 years of experience
Abstract
Background/Aim. Coxarthrosis is a chronic degenerative joint disorder which occurs in approximately 4% of population, and bilateral occurrence is estimated at 42%. Patients with bilateral coxarthrosis can undergo bilateral hip replacement in one or two stage procedure. Aim of this article was to present our experience in simultaneous bilateral hip arthroplasty, and to recommend it in patients with adequate indications. Methods. We processed data for 113 patients of both genders, operated at the Clinic for Orthopedic Surgery and Traumatology of the Military Medical Academy in Belgrade, Serbia from 2005 until 2015 where single stage bilateral hip arthroplasty was performed. Identical operative technique was applied in all patients as well as standard antibiotic and thromboprophylactic treatment. Follow-up period was 30 days postoperatively. Results. Mean age of patients was 56 ± 10.2 years, whereby 45 (39.8%) of them were males and 68 (60.2%) females. Primary coxarthrosis was etiologic factor for the majority of patients, 69 (61.1%). Postoperative hospitalization duration was 10.3 days on average (range from 3 to 34 days). We noticed the following complications: one luxation of the endoprosthesis, one deep infection and one thrombosis of the leg. There was no mortality. Majority of operated patients were grouped as the American Society of Anesthesiologists (ASA) scores 1-3. Mean blood transfusion was 1,275 mL (range from 300 to 2,830 mL). Conclusion. One stage bilateral hip arthroplasty can be performed routinely and safely in facilities with possibility for interdisciplinary approach and adequate selection of patients. Data from our study which indicate significantly increased need for blood substitution, emphasize the need to introduce contemporary perioperative blood loss management principles. The rate of complications observed in our study was within rates published in the literature concerning hip arthroplasty.
References
Allen K, Golightly Y. State of the evidence. Curr Opin Rheu-matol 2015; 27(3): 276-283.
Aghayev E, Beck A, Staub L, Dietrich D, Melloh M, Orljanski W, at al. Simultaneous bilateral hip replacement reveals superior outcome and fewer complications than two- stage procedures: a prospective study including 1819 patients and 5801 follow-ups from a total joint replacement registry. BMC Musculo-skelet Disord 2010; 11: 245.
Stavrakis AI, SooHoo NF, Lieberman JR. Bilateral Total Hip Ar-throplasty has Similar Complication Rates to Unilateral Total Hip Arthroplasty. J Arthroplasty 2015; 30(7): 1211–4.
Garland A, Rolfson O, Garellick G, Kärrholm J, Hailer N. Early postoperative mortality after simultaneous or staged bilateral primary total hip arthroplasty: an observational register study from the swedish Hip arthroplasty register. BMC Musculo-skelet Disord 2015; 16: 77.
Trojani C, d’Ollone T, Saragaglia D, Vielpeau C, Carles M, Pru-dhon JL. One stage bilateral total hip arthroplasty: Functional outcome and complications in 112 patients Orthop Traumatol Surg Res 2012; 98(6): S120–3.
Namba RS, Inacio MC, Paxton EW. Risk factors associated with surgical site infection in 30 491 primary total hip replace-ments. J Bone Joint Surg Br 2012; 94(10): 1330–8.
Berend ME, Ritter MA, Harty LD, Davis KE, Keating EM, Meding JB, at al. Simultaneous bilateral versus unilateral total hip arthroplasty. J Arthroplasty 2005; 20(4): 421–6.
Berend KR, Lombardi AV Jr, Adams JB. Simultaneous vs staged cementless bilateral total hip arthroplasty: perioperative risk comparison. J Arthroplasty 2007; 22(6 Suppl 2): 111–5.
Yeager AM, Ruel AV, Westrich GH. Are bilateral total joint ar-throplasty patients at a higher risk of developing pulmonary embolism following total hip and knee surgery? J Arthroplasty 2014; 29(5): 900–2.
Rasouli MR, Maltenfort MG, Ross D, Hozack WJ, Memtsoudis SG, Parvizi J. Perioperative morbidity and mortality following bilateral total hip arthroplasty. J Arthroplasty 2014; 29(1): 142–8.
Glait SA, Khatib ON, Bansal A, Hochfelder JP, Slover JD. Com-paring the incidence and clinical data for simultaneous bilat-eral versus unilateral total hip arthroplasty in NewYork State between 1990 and 2010. J Arthroplasty 2015; 30(11): 1887–91.
Popović Z, Rajović J, Radunović A. Total bilateral hip arthroplasty in one surgical procedure. Vojnosanit Pregl 2007; 64(10): 697–700. (Serbian)
Lamo-Espinosa J, Troncoso S, Valentí-Azcárate A, Díaz de Rada P, Valentí-Nín JR. Clinical and radiological short-term complica-tions after single stage bilateral uncemented total hip arthro-plasty. Musculoskelet Surg 2015; 99(1): 67–73.
Romagnoli S, Zacchetti S, Perazzo P, Verde F, Banfi G, Viganò M. Simultaneous bilateral total hip arthroplasties do not lead to higher complication or allogeneic transfusion rates compared to unilateral procedures. Int Orthop 2013; 37(11): 2125–30.
Reuben JD, Meyers SJ, Cox DD, Elliott M, Watson M, Shim SD. Cost comparison between bilateral simultaneous, staged, and unilateral total joint arthroplasty. J Arthroplasty 1998; 13(2): 172–9.
Wykman A., Olsson E. Walking ability after total hip arthro-plasty: a comparison of gait analysis in unilateral and bilateral cases. J Bone Joint Surg Br 1992; 74(1): 53–6.
Lazansky M. A Study of Bilateral LowFriction Arthroplasty. Internal Publication No. 3. Appley Bridge, UK: Centre for Hip Surgery, Wrightington Hospital; 1967.
Jaffe WL, Charnley J. Bilateral Charnley low-friction arthro-plasty as a single operative procedure. A report of fifty cases. Bull Hosp Joint Dis 1971; 32(2): 198–214.
Macaulay W, Salvati EA, Sculco TP, Pellicci PM. Single-stage bi-lateral total hip arthroplasty. J Am Acad Orthop Surg 2002; 10(3): 217–21.
Parvizi J, Tarity TD, Sheikh E, Sharkey PF, Hozack WJ, Rothman RH. Bilateral total hip arthroplasty: one-stage versus two-stage procedures. Clin Orthop Relat Res 2006; 453: 137–41.
Bhan S, Pankaj A, Malhotra R. One- or two-stage bilateral to-tal hip arthroplasty: a prospective, randomised, controlled study in an Asian population. J Bone Joint Surg Br 2006; 88(3): 298–303.
Samama CM, Ravaud P, Parent F, Barre J, Mertl P, Mismetti P. Epidemiology of venous thromboembolism after lower limb arthroplasty: the FOTO study. J Thromb Haemost 2007; 5(12): 2360–7.
Liu SS, Della Valle AG, Besculides MC, Gaber LK, Memtsoudis SG. Trends in mortality, complications, and demographics for primary hip arthroplasty in the United States. Int Orthop 2009; 33(3): 643–51.
Jaekel DJ, Ong KL, Lau EC, Watson HN, Kurtz SM. Epidemi-ology of total hip and knee arthroplasty infection. In: Springer BD, Parvizi J, editors. Periprosthetic joint infection of the hip and knee. New York: Springer; 2014. pp. 1–14. Chapter 1.
Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infec-tion burden for hip and knee arthroplasty in the United States. J Arthroplasty 2008; 23(7): 984–91.
Skutek M, Bourne RB, MacDonald SJ. (i) International epidemi-ology of revision THR. Curr Orthop 2006; 20(3): 157–61.
Sanchez-Sotelo J, Berry DJ. Epidemiology of instability after to-tal hip replacement. Orthop Clin North Am 2001; 32(4): 543–52, vii.
Patel PD, Potts A, Froimson MI. The dislocating hip arthroplas-ty: prevention and treatment. J Arthroplasty 2007; 22(4 Suppl 1): 86–90.
Innerhofer P, Walleczek C, Luz G, Hobisch-Hagen P, Benzer A, Stöckl B, et al. Transfusion of buffy coat-depleted blood components and risk of postoperative infection in orthopedic patients. Transfusion 1999; 39(6): 625–32.
Rawn J. The silent risks of blood transfusion. Curr Opin An-aesthesiol 2008; 21(5): 664–8.
Aderinto J, Brenkel IJ. Pre-operative predictors of the require-ment for blood transfusion following total hip replacement. J Bone Joint Surg Br 2004; 86(7): 970–3.
Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, et al. Orthopedic Surgery Transfu-sion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003; 43(4): 459–69.